Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Neurodevelopment in Children
NCT07194109Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Oct 2025
- Primary completion
- Oct 2030
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of remimazolam in Adenotonsillar hypertrophy (ATH), sponsored by First Affiliated Hospital of Anhui Medical University. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Adenotonsillar hypertrophy (ATH)
Beyond the preview
Go deeper on NCT07194109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07194109.